Amparo C. Villablanca
University of California
Davis
California 95616-8636
USA
Name/email consistency: high
- Outcomes of comprehensive heart care programs in high-risk women. Villablanca, A.C., Beckett, L.A., Li, Y., Leatherwood, S., Gill, S.K., Giardina, E.G., Barron, C., Foody, J.M., Haynes, S., D'Onofrio, G. J. Womens. Health. (Larchmt) (2010)
- 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice. Villablanca, A.C., Tenwolde, A., Lee, M., Huck, M., Mumenthaler, S., Rutledge, J.C. J. Cardiovasc. Transl. Res (2009)
- Outcomes of national community organization cardiovascular prevention programs for high-risk women. Villablanca, A.C., Arline, S., Lewis, J., Raju, S., Sanders, S., Carrow, S. J. Cardiovasc. Transl. Res (2009)
- Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor alpha. Villablanca, A., Lubahn, D., Shelby, L., Lloyd, K., Barthold, S. Arterioscler. Thromb. Vasc. Biol. (2004)
- Differential regulation of gene expression by ovariectomy in mouse aorta. Villablanca, A.C., Lewis, K.A., Tham, D., Rutledge, J.C. Physiol. Genomics (2003)
- Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. Villablanca, A.C. J. Appl. Physiol. (1998)
- Heart disease during pregnancy. Which cardiovascular changes are normal or transient?. Villablanca, A.C. Postgrad. Med (1998)
- Heart disease during pregnancy. Which cardiovascular changes reflect disease?. Villablanca, A.C. Postgrad. Med (1998)
- 17beta-estradiol stimulates substance P receptor gene expression. Villablanca, A.C., Hanley, M.R. Mol. Cell. Endocrinol. (1997)
- Coronary heart disease in women. Gender differences and effects of menopause. Villablanca, A.C. Postgrad. Med (1996)